💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

European shares rise for 7th consecutive session

Published 03/08/2010, 03:19 AM
Updated 03/08/2010, 03:28 AM

LONDON, March 8 (Reuters) - European shares rose for a seventh consecutive session early on Monday as concerns eased over the fiscal situation in Greece, with banks featuring among the biggest gainers, though drugmakers came under pressure.

By 0808 GMT, the pan-European FTSEurofirst 300 index of top shares was up 0.1 percent at 1,055.53 points.

Banks featured among the biggest movers on the index. Banco Santander, BBVA, UniCredit and Barclays gained 0.6 to 1.5 percent. "The market is a little more positive, buoyed by what happened in the United States on Friday with the non-farm payroll figures," said Justin Urquhart Stewart, director at Seven Investment Management.

"There is also a view that while Europe has not resolved its problems, the worst of what has happened to Greece has passed for the moment ... but, that is not to say it can not come back."

Central bank governor George Provopoulos said in a German newspaper interview released on Monday that Greece will not need foreign help to deal with its debt problems.

Drugmakers were the major losers, with AstraZeneca down 0.6 percent after it said its cancer drug Recentin failed in a head-to-head late stage trial with Roche's Avastin on colorectal cancer patients. (Reporting by Joanne Frearson; Editing by David Holmes)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.